Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2020

01-03-2020 | Pancreatectomy | Case Report

Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Causing Duodenal Infiltration and Obstruction: a Case Report

Authors: Narendra Pandit, Tek Narayan Yadav, Robal Lacoul, Laligen Awale

Published in: Journal of Gastrointestinal Cancer | Issue 1/2020

Login to get access

Excerpt

Intraductal papillary mucinous neoplasms (IPMNs) are rare group of pancreatic epithelial neoplasm characterized by mucin production and diffuse or segmental involvement of the main pancreatic duct (MPD) or major side branches. It comprises only 1–2% of all exocrine pancreatic neoplasm and around 20 to 50% of all cystic pancreatic neoplasm [1, 2]. Histologically, IPMNs are composed of mucin-producing columnar cells showing papillary proliferation, cyst formation, and varying degree of cellular atypia. They follow an orderly progression from low grade to moderate dysplasia to high-grade dysplasia, and finally to invasive carcinoma. Hence, these lesions can be identified grossly and radiographically before the development of invasive cancer, providing an opportunity for early interventions, analogous to colonic cancer [2]. …
Literature
1.
go back to reference Grützmann R, Niedergethmann M, Pilarsky C, Klöppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15(12):1294–309.CrossRef Grützmann R, Niedergethmann M, Pilarsky C, Klöppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15(12):1294–309.CrossRef
2.
go back to reference Fong ZV, Fernández-Del Castillo C. Intraductal papillary mucinous neoplasm of the pancreas. Surg Clin North Am. 2016;96(6):1431–45.CrossRef Fong ZV, Fernández-Del Castillo C. Intraductal papillary mucinous neoplasm of the pancreas. Surg Clin North Am. 2016;96(6):1431–45.CrossRef
3.
go back to reference Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, et al. Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg. 2006;243(5):673–80.CrossRef Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, et al. Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg. 2006;243(5):673–80.CrossRef
4.
go back to reference Valsangkar NP, Morales-Oyarvide V, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152(3 Suppl 1):S4–12.CrossRef Valsangkar NP, Morales-Oyarvide V, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152(3 Suppl 1):S4–12.CrossRef
5.
go back to reference Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46(6):479–93.CrossRef Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, et al. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46(6):479–93.CrossRef
6.
go back to reference DiMaio CJ. Current guideline controversies in the management of pancreatic cystic neoplasms. Gastrointest Endosc Clin N Am. 2018;28(4):529–47.CrossRef DiMaio CJ. Current guideline controversies in the management of pancreatic cystic neoplasms. Gastrointest Endosc Clin N Am. 2018;28(4):529–47.CrossRef
7.
go back to reference European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789–804.CrossRef European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789–804.CrossRef
8.
go back to reference Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.CrossRef Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.CrossRef
9.
go back to reference Wang W, Zhang L, Chen L, Wei J, Sun Q, Xie Q, et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Biomed Rep. 2015;3(1):43–50.CrossRef Wang W, Zhang L, Chen L, Wei J, Sun Q, Xie Q, et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Biomed Rep. 2015;3(1):43–50.CrossRef
10.
go back to reference Stauffer JA, Nguyen JH, Heckman MG, Grewal MS, Dougherty M, Gill KR, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11(6):483–92.CrossRef Stauffer JA, Nguyen JH, Heckman MG, Grewal MS, Dougherty M, Gill KR, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11(6):483–92.CrossRef
11.
go back to reference Farnell MB. Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg. 2008;12(3):414–6.CrossRef Farnell MB. Surgical management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. J Gastrointest Surg. 2008;12(3):414–6.CrossRef
12.
go back to reference Marchegiani G, Andrianello S, Perri G, Bonamini D, De Robertis R, Malleo G, et al. Vanishing pancreatic cysts during follow-up: another step towards de-emphasizing cyst size as a major clinical predictor of malignancy. Dig Surg. 2018;35(6):508–13.CrossRef Marchegiani G, Andrianello S, Perri G, Bonamini D, De Robertis R, Malleo G, et al. Vanishing pancreatic cysts during follow-up: another step towards de-emphasizing cyst size as a major clinical predictor of malignancy. Dig Surg. 2018;35(6):508–13.CrossRef
13.
go back to reference Rossi RE, Massironi S. Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. Expert Rev Gastroenterol Hepatol. 2018;12(11):1123–33.CrossRef Rossi RE, Massironi S. Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge. Expert Rev Gastroenterol Hepatol. 2018;12(11):1123–33.CrossRef
Metadata
Title
Invasive Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Causing Duodenal Infiltration and Obstruction: a Case Report
Authors
Narendra Pandit
Tek Narayan Yadav
Robal Lacoul
Laligen Awale
Publication date
01-03-2020
Publisher
Springer US
Keyword
Pancreatectomy
Published in
Journal of Gastrointestinal Cancer / Issue 1/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00225-w

Other articles of this Issue 1/2020

Journal of Gastrointestinal Cancer 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.